Sodium thiosulfate, bisphosphonates, and cinacalcet for calciphylaxis.
Raymond
Colette B
CB
Winnipeg Regional Health Authority Manitoba Renal Program. craymond@exchange.hsc.mb.ca
Wazny
Lori D
LD
Sood
Amy R
AR
D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002115:Calciphylaxis / Q000150:complications / Q000188:drug therapy*; D002170:Canada; D002614:Chelating Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000069449:Cinacalcet; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D009281:Naphthalenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006435:Renal Dialysis / Q000009:adverse effects; D013885:Thiosulfates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D050071:Bone Density Conservation Agents; D002614:Chelating Agents; D004164:Diphosphonates; D009281:Naphthalenes; D013885:Thiosulfates; C017717:sodium thiosulfate; D000069449:Cinacalcet